Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Karen A. Herzig is active.

Publication


Featured researches published by Karen A. Herzig.


Transplantation | 2000

A COMPARISON OF THE EFFECTS OF DIALYSIS AND RENAL TRANSPLANTATION ON THE SURVIVAL OF OLDER UREMIC PATIENTS

David W. Johnson; Karen A. Herzig; David M. Purdie; Allison M. Brown; R. Rigby; David L. Nicol; Carmel M. Hawley

BACKGROUND Patients over age 60 constitute half of all new patients accepted into the renal replacement therapy programs in Australia. However, the optimal treatment of their end-stage renal disease remains controversial. The aim of the present study was to compare survival for dialysis and renal transplantation in older patients who were rigorously screened and considered eligible for transplantation. METHODS The study cohort consisted of 174 consecutive patients over 60 who were accepted on to the Queensland cadaveric renal transplant waiting list between January 1, 1993 and December 31, 1997. Follow-up was terminated on October 1, 1998. Data were analyzed on an intention-to-transplant basis using a Cox regression model with time-varying explanatory variables. An alternative survival analysis was also performed, in which patients no longer considered suitable for transplantation were censored at the time of their removal from the waiting list. RESULTS There were 67 patients receiving a renal transplant, whereas the other 107 continued to undergo dialysis. These two groups were well matched at baseline with respect to age, gender, body mass index, renal disease etiology, comorbid illnesses, and dialysis duration and modality. The overall mortality rate was 0.096 per patient-year (0.131 for dialysis and 0.029 for transplant, P<0.001). Respective 1-, 3- and 5-year survivals were 92%, 62%, and 27% for the dialysis group and 98%, 95%, and 90% (P<0.01) for the transplant group. Patients in the transplant group had an adjusted hazard ratio 0.16 times that of the dialysis group (95% confidence interval 0.06-0.42). If patients were censored at the time of their withdrawal from the transplant waiting list, the adjusted hazard ratio was 0.24 (95% confidence interval 0.09-0.69). CONCLUSIONS Renal transplantation seems to confer a substantial survival advantage over dialysis in patients with end-stage renal failure who are rigorously screened and considered suitable for renal transplantation.


Journal of The American Society of Nephrology | 2001

Is C-Reactive Protein a Useful Predictor of Outcome in Peritoneal Dialysis Patients?

Karen A. Herzig; David M. Purdie; Wendy Chang; Allison M. Brown; Carmel M. Hawley; Scott B. Campbell; J. Sturtevant; Nicole M. Isbel; David L. Nicol; David W. Johnson


Peritoneal Dialysis International | 2000

Is obesity a favorable prognostic factor in peritoneal dialysis patients

David W. Johnson; Karen A. Herzig; David M. Purdie; Wendy Chang; Allison M. Brown; R. Rigby; Scott B. Campbell; David L. Nicol; Carmel M. Hawley


Transplant International | 2003

A single-centre experience of post-renal transplant lymphoproliferative disorder

Karen A. Herzig; Helen G. Juffs; Debra Norris; Allison M. Brown; Devinder Gill; Carmel M. Hawley; Ralph Cobcroft; James J.B. Petrie; Paula Marlton; D. Thomson; Scott B. Campbell; David L. Nicol; David W. Johnson


Nephrology Dialysis Transplantation | 2001

A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients

David W. Johnson; Karen A. Herzig; Ruth Gissane; Scott B. Campbell; Carmel M. Hawley; Nicole M. Isbel


Nephrology Dialysis Transplantation | 1999

Marked elevation of blood cyclosporin and tacrolimus levels due to concurrent metronidazole therapy.

Karen A. Herzig; David W. Johnson


Nephrology Dialysis Transplantation | 2000

Isolated tuberculous pyomyositis in a renal transplant patient

David W. Johnson; Karen A. Herzig


Peritoneal Dialysis International | 2001

Oral versus intravenous iron supplementation in peritoneal dialysis patients

David W. Johnson; Karen A. Herzig; Ruth Gissane; Scott B. Campbell; Carmel M. Hawley; Nicole M. Isbel


Transplantation | 2000

Novel surveillance and cure of a donor-transmitted lymphoma in a renal allograft recipient.

Karen A. Herzig; M. Falk; Julie R. Jonsson; Roy A. Axelsen; A. Griffin; Carmel M. Hawley; R. Rigby; Ralph Cobcroft; David L. Nicol; Elizabeth E. Powell; David W. Johnson


Transplantation Proceedings | 2003

Durable and high rates of remission following chemotherapy in posttransplantation lymphoproliferative disorders after renal transplantation.

D Gill; H.G Juffs; Karen A. Herzig; Allison M. Brown; Carmel M. Hawley; Ralph Cobcroft; J Petrie; Paula Marlton; Glen A. Kennedy; D. Thomson; Scott B. Campbell; David L. Nicol; Debra Norris; David W. Johnson

Collaboration


Dive into the Karen A. Herzig's collaboration.

Top Co-Authors

Avatar

David W. Johnson

Princess Alexandra Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David L. Nicol

Princess Alexandra Hospital

View shared research outputs
Top Co-Authors

Avatar

Scott B. Campbell

Princess Alexandra Hospital

View shared research outputs
Top Co-Authors

Avatar

Allison M. Brown

Princess Alexandra Hospital

View shared research outputs
Top Co-Authors

Avatar

David M. Purdie

QIMR Berghofer Medical Research Institute

View shared research outputs
Top Co-Authors

Avatar

R. Rigby

Princess Alexandra Hospital

View shared research outputs
Top Co-Authors

Avatar

Nicole M. Isbel

Princess Alexandra Hospital

View shared research outputs
Top Co-Authors

Avatar

Ralph Cobcroft

Princess Alexandra Hospital

View shared research outputs
Top Co-Authors

Avatar

Andrew Bofinger

Princess Alexandra Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge